Top

Journal of Cardiovascular Translational Research

Published in:

01-04-2010

Stem Cell Therapy for Chronic Myocardial Infarction

Authors: Manuel Mazo, Beatriz Pelacho, Felipe Prósper

Published in: Journal of Cardiovascular Translational Research | Issue 2/2010

Abstract

Although recent advances for the treatment of myocardial infarction have dramatically increased the rate of survival after the ischemic event, this has also led to a rise in the number of chronic patients, making the finding of a suitable therapy a compulsory subject for modern medicine. Over the last decade, stem cells have been a promise for the cure of several diseases not only due to their plasticity but also to their capacity to act in a paracrine manner and influence the affected tissue, prompting the launching of several clinical trials. In spite of the knowledge already acquired, stem cell application to chronically infarcted hearts has been much less approached than its acute counterpart. Through this review, we will focus in stem cell therapy in animal models of chronic myocardial infarction: cell types employed, functional results, mechanisms analyzed, and questions raised.

Adamopoulos, S., Parissis, J. T., & Kremastinos, D. T. (2001). A glossary of circulating cytokines in chronic heart failure. European Journal of Heart Failure, 3, 517–526.CrossRefPubMed

Agbulut, O., Mazo, M., Bressolle, C., Gutierrez, M., Azarnoush, K., Sabbah, L., et al. (2006). Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovascular Research, 72, 175–183.CrossRefPubMed

Armstrong, P. W., Granger, C. B., Adams, P. X., Hamm, C., Holmes, D., Jr., O'Neill, W. W., et al. (2007). Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial. JAMA, 297, 43–51.CrossRefPubMed

Bai, X., Pinkernell, K., Song, Y. H., Nabzdyk, C., Reiser, J., & Alt, E. (2007). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochemical and Biophysical Research Communications, 353, 665–671.CrossRefPubMed

Behfar, A., Faustino, R. S., Arrell, D. K., Dzeja, P. P., Perez-Terzic, C., & Terzic, A. (2008). Guided stem cell cardiopoiesis: Discovery and translation. Journal of Molecular and Cellular Cardiology, 45, 523–529.CrossRefPubMed

Bonaros, N., Rauf, R., Werner, E., Schlechta, B., Rohde, E., Kocher, A., et al. (2008). Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact Cardiovasc Thorac Surg, 7, 249–255.CrossRefPubMed

Bonaros, N., Rauf, R., Wolf, D., Margreiter, E., Tzankov, A., Schlechta, B., et al. (2006). Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. Journal of Thoracic and Cardiovascular Surgery, 132, 1321–1328.CrossRefPubMed

Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., et al. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 110, 1362–1369.CrossRefPubMed

Bujak, M. & Frangogiannis, N. G. (2007). The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovascular Research, 74, 184–195.CrossRefPubMed

10.

Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., et al. (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of the American College of Cardiology, 50, 1884–1893.CrossRefPubMed

11.

Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V., & Weber, K. T. (1995). Regulation of collagen degradation in the rat myocardium after infarction. Journal of Molecular and Cellular Cardiology, 27, 1281–1292.CrossRefPubMed

12.

Chang, S. A., Lee, E. J., Kang, H. J., Zhang, S. Y., Kim, J. H., Li, L., et al. (2008). Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: Effect of acute myocardial infarction on stem cell differentiation. Stem Cells, 26, 1901–1912.CrossRefPubMed

13.

Desmouliere, A., Chaponnier, C., & Gabbiani, G. (2005). Tissue repair, contraction, and the myofibroblast. Wound Repair and Regeneration, 13, 7–12.CrossRefPubMed

14.

Deten, A., Volz, H. C., Briest, W., & Zimmer, H. G. (2002). Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Research, 55, 329–340.CrossRefPubMed

15.

Ertl, G. & Frantz, S. (2005). Healing after myocardial infarction. Cardiovascular Research, 66, 22–32.CrossRefPubMed

16.

Farahmand, P., Lai, T. Y., Weisel, R. D., Fazel, S., Yau, T., Menasche, P., et al. (2008). Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation, 118, S130–137.CrossRefPubMed

17.

Fishbein, M. C., Maclean, D., & Maroko, P. R. (1978). Experimental myocardial infarction in the rat: Qualitative and quantitative changes during pathologic evolution. American Journal of Pathology, 90, 57–70.PubMed

18.

Frangogiannis, N. G., Perrard, J. L., Mendoza, L. H., Burns, A. R., Lindsey, M. L., Ballantyne, C. M., et al. (1998). Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation, 98, 687–698.PubMed

19.

Frangogiannis, N. G., Smith, C. W., & Entman, M. L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research, 53, 31–47.CrossRefPubMed

20.

Fukushima, S., Coppen, S. R., Lee, J., Yamahara, K., Felkin, L. E., Terracciano, C. M., et al. (2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE, 3, e3071.CrossRefPubMed

21.

Fyhrquist, F. & Saijonmaa, O. (2008). Renin–angiotensin system revisited. Journal of Internal Medicine, 264, 224–236.CrossRefPubMed

22.

Gavira, J. J., Herreros, J., Perez, A., Garcia-Velloso, M. J., Barba, J., Martin-Herrero, F., et al. (2006). Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. Journal of Thoracic and Cardiovascular Surgery, 131, 799–804.CrossRefPubMed

23.

Gavira, J. J., Nasarre, E., Abizanda, G., Perez-Ilzarbe, M., de Martino-Rodriguez, A., Garcia de Jalon, J. A. et al. (2009). Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. European Heart Journal (in press).

24.

Gavira, J. J., Perez-Ilzarbe, M., Abizanda, G., Garcia-Rodriguez, A., Orbe, J., Paramo, J. A., et al. (2006). A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovascular Research, 71, 744–753.CrossRefPubMed

25.

Hamad, E., Mather, P. J., Srinivasan, S., Rubin, S., Whellan, D. J., & Feldman, A. M. (2007). Pharmacologic therapy of chronic heart failure. American Journal of Cardiovascular Drugs, 7, 235–248.CrossRefPubMed

26.

He, Q., Trindade, P. T., Stumm, M., Li, J., Zammaretti, P., Bettiol, E., et al. (2009). Fate of undifferentiated mouse embryonic stem cells within the rat heart: Role of myocardial infarction and immune suppression. Journal of Cellular and Molecular Medicine, 13, 188–201.CrossRefPubMed

27.

Holmes, J. W., Borg, T. K., & Covell, J. W. (2005). Structure and mechanics of healing myocardial infarcts. Annual Review of Biomedical Engineering, 7, 223–253.CrossRefPubMed

28.

Irwin, M. W., Mak, S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A., et al. (1999). Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation, 99, 1492–1498.PubMed

29.

Kastrup, J., Ripa, R. S., Wang, Y., & Jorgensen, E. (2006). Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: A non-invasive alternative for clinical stem cell therapy? European Heart Journal, 27, 2748–2754.CrossRefPubMed

30.

Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678–685.CrossRefPubMed

31.

Koh, G. Y., Klug, M. G., Soonpaa, M. H., & Field, L. J. (1993). Differentiation and long-term survival of C2C12 myoblast grafts in heart. Journal of Clinical Investigation, 92, 1548–1554.CrossRefPubMed

32.

Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25, 1015–1024.CrossRefPubMed

33.

Landa, N., Miller, L., Feinberg, M. S., Holbova, R., Shachar, M., Freeman, I., et al. (2008). Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation, 117, 1388–1396.CrossRefPubMed

34.

Le Blanc, K. (2006). Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy, 8, 559–561.CrossRefPubMed

35.

Leobon, B., Roncalli, J., Joffre, C., Mazo, M., Boisson, M., Barreau, C., et al. (2009). Adipose-derived cardiomyogenic cells: In vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovascular Research, 83, 757–767.CrossRefPubMed

36.

Li, L., Zhang, S., Zhang, Y., Yu, B., Xu, Y., & Guan, Z. (2008). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Molecular Biology Reports, 36, 725–731.CrossRefPubMed

37.

Li, R. K., Mickle, D. A., Weisel, R. D., Rao, V., & Jia, Z. Q. (2001). Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Annals of Thoracic Surgery, 72, 1957–1963.CrossRefPubMed

38.

Li, S. H., Lai, T. Y., Sun, Z., Han, M., Moriyama, E., Wilson, B., et al. (2009). Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. Journal of Thoracic and Cardiovascular Surgery, 137, 1225–1233. e1221.CrossRefPubMed

39.

Liu, J. F., Wang, B. W., Hung, H. F., Chang, H., & Shyu, K. G. (2008). Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction. Journal of the Formosan Medical Association, 107, 165–174.CrossRefPubMed

40.

Mann, D. L. (1999). Mechanisms and models in heart failure: A combinatorial approach. Circulation, 100, 999–1008.PubMed

41.

Mann, D. L., Deswal, A., Bozkurt, B., & Torre-Amione, G. (2002). New therapeutics for chronic heart failure. Annual Review of Medicine, 53, 59–74.CrossRefPubMed

42.

Martinez-Fernandez, A., Nelson, T. J., Yamada, S., Reyes, S., Alekseev, A. E., Perez-Terzic, C., et al. (2009). iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circulation Research, 105, 648–656.CrossRefPubMed

43.

Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L. S., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118, 507–517.CrossRefPubMed

44.

Mazo, M. (2009). Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant. doi:10.3727/096368909X480323.

45.

Mazo, M., Planat-Benard, V., Abizanda, G., Pelacho, B., Leobon, B., Gavira, J. J., et al. (2008). Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. European Journal of Heart Failure, 10, 454–462.CrossRefPubMed

46.

Menasche, P. (2009). Stem cell therapy for heart failure: Are arrhythmias a real safety concern? Circulation, 119, 2735–2740.CrossRefPubMed

47.

Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First randomized placebo-controlled study of myoblast transplantation. Circulation, 117, 1189–1200.CrossRefPubMed

48.

Merx, M. W., Zernecke, A., Liehn, E. A., Schuh, A., Skobel, E., Butzbach, B., et al. (2005). Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Research in Cardiology, 100, 208–216.CrossRefPubMed

49.

Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M. H. et al. (2009). Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells, 27(11), 2734–2743.

50.

Miranville, A., Heeschen, C., Sengenes, C., Curat, C. A., Busse, R., & Bouloumie, A. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation, 110, 349–355.CrossRefPubMed

51.

Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12, 459–465.CrossRefPubMed

52.

Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., et al. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. Journal of Experimental Medicine, 204, 3037–3047.CrossRefPubMed

53.

Nakajima, H., Sakakibara, Y., Tambara, K., Marui, A., Yoshimoto, M., Premaratne, G. U., et al. (2008). Delivery route in bone marrow cell transplantation should be optimized according to the etiology of heart disease. Circ J, 72, 1528–1535.CrossRefPubMed

54.

Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., Terzic, A. (2009) Repair of acute myocardial infarction with induced pluripotent stem cells induced by human stemness factors. Circulation. doi:10.1161/CIRCULATIONAHA.109.865154.

55.

Nian, M., Lee, P., Khaper, N., & Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research, 94, 1543–1553.CrossRefPubMed

56.

Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB Journal, 21, 1345–1357.CrossRefPubMed

57.

Organization WH (2004) The world health report 2004.

58.

Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., & Anversa, P. (2001). Transplanted adult bone marrow cells repair myocardial infarcts in mice. Annals of the New York Academy of Sciences, 938, 221–229. discussion 229–230.PubMedCrossRef

59.

Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.CrossRefPubMed

60.

Ott, H. C., Matthiesen, T. S., Goh, S. K., Black, L. D., Kren, S. M., Netoff, T. I., et al. (2008). Perfusion-decellularized matrix: Using nature’s platform to engineer a bioartificial heart. Nature Medicine, 14, 213–221.CrossRefPubMed

61.

Pearl, J. & Wu, J. C. (2008). Seeing is believing: Tracking cells to determine the effects of cell transplantation. Seminars in Thoracic and Cardiovascular Surgery, 20, 102–109.CrossRefPubMed

62.

Pelacho, B. & Prosper, F. (2008). Stem cells and cardiac disease: Where are we going? Curr Stem Cell Res Ther, 3, 265–276.CrossRefPubMed

63.

Perez-Ilzarbe, M., Agbulut, O., Pelacho, B., Ciorba, C., San, Jose-Eneriz E., Desnos, M., et al. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. European Journal of Heart Failure, 10, 1065–1072.CrossRefPubMed

64.

Pfannkuche, K., Liang, H., Hannes, T., Xi, J., Fatima, A., Nguemo, F., et al. (2009). Cardiac myocytes derived from murine reprogrammed fibroblasts: Intact hormonal regulation, cardiac ion channel expression and development of contractility. Cellular Physiology and Biochemistry, 24, 73–86.CrossRefPubMed

65.

Phillips, H. R., O’Connor, C. M., & Rogers, J. (2007). Revascularization for heart failure. American Heart Journal, 153, 65–73.CrossRefPubMed

66.

Planat-Benard, V., Menard, C., Andre, M., Puceat, M., Perez, A., Garcia-Verdugo, J. M., et al. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circulation Research, 94, 223–229.CrossRefPubMed

67.

Puymirat, E., Geha, R., Tomescot, A., Bellamy, V., Larghero, J., Trinquart, L., et al. (2009). Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Molecular Therapy, 17, 176–182.CrossRefPubMed

68.

Richard, V., Murry, C. E., & Reimer, K. A. (1995). Healing of myocardial infarcts in dogs. Effects of late reperfusion. Circulation, 92, 1891–1901.PubMed

69.

Roger, V. L., Weston, S. A., Redfield, M. M., Hellermann-Homan, J. P., Killian, J., Yawn, B. P., et al. (2004). Trends in heart failure incidence and survival in a community-based population. Jama, 292, 344–350.CrossRefPubMed

70.

Rossen, R. D., Michael, L. H., Kagiyama, A., Savage, H. E., Hanson, G., Reisberg, M. A., et al. (1988). Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circulation Research, 62, 572–584.PubMed

71.

Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., et al. (2007). Bone marrow cells adopt the cardiomyogenic fate in vivo. Proceedings of the National Academy of Sciences of the United States of America, 104, 17783–17788.CrossRefPubMed

72.

Schaffler, A. & Buchler, C. (2007). Concise review: Adipose tissue-derived stromal cells—Basic and clinical implications for novel cell-based therapies. Stem Cells, 25, 818–827.CrossRefPubMed

73.

Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., et al. (2009). Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. European Heart Journal, 30, 2722–2732.CrossRefPubMed

74.

Segers, V. F. & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451, 937–942.CrossRefPubMed

75.

Shanmugam, G. & Legare, J. F. (2008). Revascularization for ischaemic cardiomyopathy. Current Opinion in Cardiology, 23, 148–152.CrossRefPubMed

76.

Shintani, Y., Fukushima, S., Varela-Carver, A., Lee, J., Coppen, S. R., Takahashi, K., et al. (2009). Donor cell type-specific paracrine effects of cell transplantation for post-infarction heart failure. Journal of Molecular and Cellular Cardiology, 47, 288–295.CrossRefPubMed

77.

Silva, G. V., Litovsky, S., Assad, J. A., Sousa, A. L., Martin, B. J., Vela, D., et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111, 150–156.CrossRefPubMed

78.

Strem, B. M., Hicok, K. C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R. E., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio Journal of Medicine, 54, 132–141.CrossRefPubMed

79.

Sun, Y., Kiani, M. F., Postlethwaite, A. E., & Weber, K. T. (2002). Infarct scar as living tissue. Basic Research in Cardiology, 97, 343–347.CrossRefPubMed

80.

Takahashi, K. & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.CrossRefPubMed

81.

Takehara, N., Tsutsumi, Y., Tateishi, K., Ogata, T., Tanaka, H., Ueyama, T., et al. (2008). Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol, 52, 1858–1865.CrossRefPubMed

82.

Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., et al. (1998). Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nature Medicine, 4, 929–933.CrossRefPubMed

83.

van Amerongen, M. J., Bou-Gharios, G., Popa, E., van Ark, J., Petersen, A. H., van Dam, G. M., et al. (2008). Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol, 214, 377–386.CrossRefPubMed

84.

Vandervelde, S., van Amerongen, M. J., Tio, R. A., Petersen, A. H., van Luyn, M. J., & Harmsen, M. C. (2006). Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc Pathol, 15, 83–90.CrossRefPubMed

85.

Virag, J. I. & Murry, C. E. (2003). Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. American Journal of Pathology, 163, 2433–2440.PubMed

86.

Waksman, R., Fournadjiev, J., Baffour, R., Pakala, R., Hellinga, D., Leborgne, L., et al. (2004). Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovasc Radiat Med, 5, 125–131.CrossRefPubMed

87.

Weisman, H. F., Bush, D. E., Mannisi, J. A., Weisfeldt, M. L., & Healy, B. (1988). Cellular mechanisms of myocardial infarct expansion. Circulation, 78, 186–201.PubMed

88.

Yu, J., Christman, K. L., Chin, E., Sievers, R. E., Saeed, M., & Lee, R. J. (2009). Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery, 137, 180–187.CrossRefPubMed

89.

Yu, J., Gu, Y., Du, K. T., Mihardja, S., Sievers, R. E., & Lee, R. J. (2008). The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials, 30, 751–756.CrossRefPubMed

90.

Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104, e30–41.CrossRefPubMed

Title: Stem Cell Therapy for Chronic Myocardial Infarction
Authors: Manuel Mazo
Beatriz Pelacho
Felipe Prósper
Publication date: 01-04-2010
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 2/2010
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-009-9159-9

2024 ASCO Annual Meeting

Springer Medicine

Stem Cell Therapy for Chronic Myocardial Infarction

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Stem Cells and Ethics: Current Issues

Dynamics of Progenitor Cells and Ventricular Assist Device Intervention

COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design

Gender Dimorphisms in Progenitor and Stem Cell Function in Cardiovascular Disease

Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study

Hypoxia-Inducible Factor 1-Alpha Release After Intracoronary Versus Intramyocardial Stem Cell Therapy in Myocardial Infarction